Novakand Pharma AB (FRA:3EE0) Days Payable: 0.00 (As of Dec. 2025)


What is Novakand Pharma AB Days Payable?

Novakand Pharma AB FRA:3EE0 Days Payable is 0.00 as of Dec. 2025. The stock has 1 warning sign investors should review.

Novakand Pharma AB's average Accounts Payable for the three months ended in Dec. 2025 was €0.00 Mil. Novakand Pharma AB's Cost of Goods Sold for the three months ended in Dec. 2025 was €0.00 Mil.

The historical rank and industry rank for Novakand Pharma AB's Days Payable or its related term are showing as below:

During the past 13 years, Novakand Pharma AB's highest Days Payable was 30950.65. The lowest was 9788.37. And the median was 15531.51.

FRA:3EE0's Days Payable is not ranked *
in the Biotechnology industry.
Industry Median: 113.56
* Ranked among companies with meaningful Days Payable only.

Novakand Pharma AB's Days Payable stayed the same from Dec. 2024 (0.00) to Dec. 2025 (0.00). stayed the same

Novakand Pharma AB Days Payable Historical Data

* Premium members only.

The historical data trend for Novakand Pharma AB's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novakand Pharma AB Days Payable Chart

Novakand Pharma AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Novakand Pharma AB Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

FRA:3EE0 vs VRTX, REGN, ALNY: Days Payable Comparison

For the Biotechnology subindustry, Novakand Pharma AB's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Novakand Pharma AB Days Payable vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Novakand Pharma AB's Days Payable distribution charts can be found below:

* The bar in red indicates where Novakand Pharma AB's Days Payable falls into.


Novakand Pharma AB Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Novakand Pharma AB's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as

Days Payable (A: Dec. 2025 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2024 ) + Accounts Payable (A: Dec. 2025 )) / count ) / Cost of Goods Sold (A: Dec. 2025 )*Days in Period
=( (0.232 + 0) / 1 ) / 0*365
=0.232 / 0*365
=N/A

Novakand Pharma AB's Days Payable for the quarter that ended in Dec. 2025 is calculated as:

Days Payable (Q: Dec. 2025 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Sep. 2025 ) + Accounts Payable (Q: Dec. 2025 )) / count ) / Cost of Goods Sold (Q: Dec. 2025 )*Days in Period
=( (0 + 0) / 1 ) / 0*365 / 4
=0 / 0*365 / 4
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 0.00 mean?
Novakand Pharma AB (FRA:3EE0) has a Days Payable of 0.00 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Novakand Pharma AB and its competitors. Over the past decade, Novakand Pharma AB's Days Payable has ranged from 9,788.37 to 30,950.65.
Is Novakand Pharma AB's Days Payable too high?
Novakand Pharma AB's current Days Payable is 0.00. Over the past 10 years, this metric has ranged from a low of 9,788.37 to a high of 30,950.65.
How does Novakand Pharma AB's Days Payable compare to VRTX and REGN?
Novakand Pharma AB's Days Payable of 0.00 can be compared against companies in the Biotechnology industry. The industry median Days Payable is 113.56. Historically, Novakand Pharma AB's own Days Payable has ranged from 9,788.37 to 30,950.65 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.56, based on 702 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Novakand Pharma AB and its competitors. For the Biotechnology industry, the median Days Payable is 113.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Novakand Pharma AB's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Novakand Pharma AB stock overvalued right now?
Novakand Pharma AB (FRA:3EE0) has a current Days Payable of 0.00. The current Days Payable is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Novakand Pharma AB (FRA:3EE0), the current Days Payable is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Novakand Pharma AB Business Description

Address Nanna Svarts vag 4, Solna, SWE, 171 65
Novakand Pharma AB is developing a new class of innovative drugs focusing on inflammatory diseases and cancer. The company is developing a new class of small molecule drugs that control disease promoting immune cells with precision, by targeting the fractalkine axis.